SCHEMBL1701378

SCHEMBL1701378

Cc1c(C(OC(C)(C)C)C(=O)O)c(-c2ccc(Cl)cc2)c2ccccc2c1C=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.48
PSIP1 O75475 1/20 0.41
AR P10275 2/20 0.40
GRM5 P41594 1/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
TP53 P04637 1/20 0.32
KCNH2 Q12809 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699749 0.92 CYP3A4 (0.50) CYP3A4PSIP1ARGRM5KMT2A
SCHEMBL10271608 0.89 CYP3A4 (0.53) CYP3A4PSIP1GRM5KMT2ALMNA
SCHEMBL1699610 0.89 AR (0.38) CYP3A4ARGRM5KMT2AKDM4E
SCHEMBL1699506 0.88 CYP3A4 (0.52) CYP3A4PSIP1KMT2ALMNA
SCHEMBL1699493 0.88 CYP3A4 (0.52) CYP3A4PSIP1GRM5KMT2ALMNA
SCHEMBL1699725 0.85 CYP3A4 (0.49) CYP3A4PSIP1GRM5KMT2ALMNA
SCHEMBL1699716 0.85 CYP3A4 (0.49) CYP3A4PSIP1GRM5KMT2ALMNA
SCHEMBL10272021 0.85 CYP3A4 (0.49) CYP3A4PSIP1GRM5KMT2ATP53
SCHEMBL1699586 0.85 CYP3A4 (0.49) CYP3A4PSIP1GRM5KMT2ALMNA
SCHEMBL1699681 0.84 CYP3A4 (0.48) CYP3A4PSIP1ARKMT2AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588450-A1 NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS Gilead Sciences, Inc. (US) 2013-05-08 EP disclosed
WO-2012003497-A1 NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS GILEAD SCIENCES, INC. (US) 2012-01-05 WO disclosed